Specialized CNS Biomarker Lab vs. CRO or Central Lab: Which Does Your Trial Need?
CROs run clinical trials, central labs run standardized safety and clinical tests, and specialized biomarker labs run the mechanism-specific assays that show whether a CNS drug is working in the brain. Most CNS programs need all three. NeuroDex is a specialized CNS biomarker lab: we isolate neuron-derived extracellular vesicles (NDEs) from plasma with our ExoSORT™ platform and measure target engagement, pharmacodynamic and disease biomarkers inside them, from preclinical studies through Phase 2b.
Side-by-side comparison
| Specialized CNS biomarker lab (NeuroDex) | CRO | Central lab | |
|---|---|---|---|
| Main role | Mechanism-specific biomarker science and testing | Runs the trial: sites, monitoring, data management, regulatory operations | Standardized clinical and safety testing across many sites |
| Typical assays | Neuron-derived TDP-43, α-synuclein, tau/pTau, AKT pathway, synaptic, autophagy and custom target assays | Usually subcontracts specialized biomarker work | Chemistry, hematology and established commercial tests |
| Neuron-specific blood biomarkers | Yes: measured inside neuron-derived vesicles from plasma | Through a specialized lab | Generally whole-plasma measurements |
| Custom target-engagement assays | Developed and qualified for your target | Through a specialized lab | Limited to validated test menus |
| Scientific input on biomarker strategy | Direct collaboration with assay scientists | Project and operations management | Testing and logistics support |
| Quality setting | CLIA-certified lab and GCLP-aligned clinical trial lab; GLP-compliant instruments | GCP trial management | Clinical laboratory accreditation |
When to use which
- Use a CRO to run trial operations: sites, enrollment, monitoring and data.
- Use a central lab for safety labs and standardized tests across many sites.
- Use a specialized CNS biomarker lab when you need to show your drug reached the brain and engaged its target, measure disease biology such as TDP-43 or α-synuclein, select patients, or develop an assay for a new target. Blood samples collected at your sites can be shipped frozen to the specialized lab.
Questions to ask any CNS biomarker partner
| Question | NeuroDex answer |
|---|---|
| Is the readout specific to the brain, or does it mix in signal from blood cells and other organs? | Neuron-specific: we isolate neuron-derived vesicles before measuring, increasing the neuronal signal more than 50-fold vs. conventional plasma analysis. |
| Has the biomarker been used in a clinical trial? | Yes. Neuron-derived TDP-43 was a registered primary outcome in the Phase 2b PARADIGM ALS trial (NCT05357950), with a significant reduction vs. placebo at Day 180. |
| How precise are the assays? | TDP-43 assay variability below 20%; α-synuclein CV below 15%; automated 96-well isolation. |
| What quality systems apply? | CLIA-certified clinical testing laboratory, GCLP-aligned clinical trial laboratory, SOPs on GLP-compliant instruments; audited by pharma sponsors. |
| Can you build an assay for our specific target? | Yes, including target-engagement assays for ASO programs. See pharmacodynamic biomarkers. |
| What sample and turnaround? | EDTA plasma (serum accepted), 500 µL minimum, frozen on dry ice; report in 2–3 weeks depending on study size. |
| Is the science published and independently funded? | Yes. See our publications; the α-synuclein program is funded by The Michael J. Fox Foundation. |
Learn more
Clinical trial biomarker services · Biomarkers by disease area · ALS & FTD · Parkinson’s · Alzheimer’s · FAQ
Frequently asked questions
Should I use a CRO or a specialized lab for CNS biomarkers?
Usually both. A CRO runs trial operations and a central lab runs standard safety tests, while a specialized CNS biomarker lab like NeuroDex runs the mechanism-specific assays that show target engagement and disease biology in the brain. CROs typically subcontract this specialized work.
Can a central lab measure neuron-specific blood biomarkers?
Central labs generally run whole-plasma tests from established menus. Measuring proteins such as TDP-43 or α-synuclein as neuron-specific markers requires first isolating neuron-derived extracellular vesicles, which NeuroDex does with its ExoSORT™ platform. Plasma collected at trial sites can be shipped frozen to NeuroDex.
How do I choose a biomarker lab for a CNS clinical trial?
Ask whether the readout is brain-specific, whether the biomarker has been used in a trial, how precise the assays are, which quality systems apply, whether they can build an assay for your target, what sample volume and turnaround they need, and whether the science is published.
Does NeuroDex replace my CRO or central lab?
No. NeuroDex works alongside them as the specialized lab for neuron-derived biomarkers, target engagement and custom assays, while your CRO runs the trial and your central lab handles standard tests.
Which CNS biomarkers can a specialized lab add?
NeuroDex adds neuron-derived TDP-43, α-synuclein, tau/pTau, AKT pathway, synaptic, autophagy (LC3, Cathepsin D) and NF-κB biomarkers, plus custom target-engagement assays, all from plasma.
What evidence supports NeuroDex biomarkers in trials?
Neuron-derived TDP-43 was a registered primary outcome in the Phase 2b PARADIGM ALS trial (NCT05357950), and NeuroDex Akt-mTOR biomarkers detected central GLP-1 and PPARγ target engagement in a 2026 JCEM study.
Planning a CNS trial? Contact our team to discuss which biomarkers your program needs and how they fit with your CRO and central lab.

